Versor Investments’s Bio-Techne TECH Stock Holding History

Versor Investments’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,386	Closed	-$2.37M	–	927
2025 Q1	$2.37M	Buy	+40,386	New	+$2.74M	0.39%	31

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Versor Investments's TECH Position: Q2 2025 in Review

Versor Investments sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 40,386 shares — an estimated $2.37M sold.

Versor Investments first reported a position in TECH in Q1 2025 and held it in 1 quarter. The position peaked at $2.37M in Q1 2025. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Versor Investments reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Versor Investments sold 40,386 Bio-Techne shares in Q2 2025, an estimated $2.37M.
Versor Investments first reported a position in Bio-Techne in Q1 2025 and held it in 1 quarter.
Versor Investments's Bio-Techne position peaked at $2.37M in Q1 2025.
554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Versor Investments's 13F filing for Q2 2025, filed 5 Aug 2025.